Quantcast
 
New ETF Book by Larry Connors - Click here to read more


 

Family sues Rohm & Haas over cancer death

Sat. April 25, 2009; Posted: 05:33 AM
Stocks RSS
Apr 25, 2009 (Philadelphia Daily News - McClatchy-Tribune Information Services via COMTEX) -- ROH | Quote | Chart | News | PowerRating -- Rohm & Haas, the Philadelphia-based chemical company, was hit yesterday with another wrongful-death lawsuit stemming from a possible cancer cluster at its research-and-development headquarters in Montgomery County.

The suit was filed in Philadelphia Common Pleas Court by Anne Snizavich, whose husband, Joseph Snizavich, a father of two, died in September at age 63 of brain cancer.

"He was a great dad," said Aaron Freiwald, the family's attorney.

Snizavich, of Norristown, contends that Rohm & Haas, now a subsidiary of Dow Chemical Co., exposed her husband to carcinogenic chemicals at its Spring House Technical Center and concealed information about potentially unsafe work conditions.

The company is facing seven similar lawsuits that Freiwald has filed on behalf of cancer victims who worked at Spring House. Attorneys for the company, which insists that the site is safe, are asking the Superior Court to strike down the suits, claiming that such complaints filed by its employees are workers' compensation cases that do not belong in court.

Yesterday's lawsuit could be legally significant because Snizavich was not a Rohm & Haas employee. He was a pipe fitter who worked at Spring House as a long-term contractor employed by Welsch Company.

If the chemical giant is unable to raise the workers' comp issue that has stalled the other lawsuits, Freiwald could be free to move forward with depositions and subpoenas.

"We've already gotten a lot of information, but now I'm hopeful that we're going to get access to a lot more that I know is there and we just haven't been given yet," he said of company memos and other documents. "For all the cases, this could be pretty significant."

Rohm & Haas spokesman Syd Havely declined to comment on the Snizavich suit yesterday because the company hadn't yet seen it. He has previously said that two in-house epidemiological studies uncovered no "statistically significant correlation" between brain tumors and chemicals at Spring House.

Those studies have been criticized by the National Institute for Occupational Safety and Health. In the Snizavich complaint, Freiwald dismissed them as "scientific frauds designed to hide the truth about the number of brain cancer cases and the causes of brain cancer" among Rohm & Haas workers.

The company has identified 12 malignant brain tumors among employees who had been assigned to Spring House, which opened in 1963. But that figure does not include Snizavich, nor two Rohm & Haas employees that weren't assigned specifically to Spring House but had worked there and died of brain cancer, Freiwald said.

"I think there are others that we still don't know about," he said.

To see more of the Philadelphia Daily News, or to subscribe to the newspaper, go
to http://www.philly.com. Copyright (c) 2009, Philadelphia Daily News
Distributed by McClatchy-Tribune Information Services. For reprints, email
tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax
to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave.,
Suite 303, Glenview, IL 60025, USA.
For full details for ROH click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [ROH]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.